Runs 154 Medicare-certified rehabilitation hospitals that take patients directly from acute care hospitals and get paid at a higher rate for doing so.
At a glance
Depends onDownstream position: depends on 12 industries, supplies 5
Scale
Market cap is above the global median
PositionGross margin is in the top 5% of Medical Care Facilities peers
Interpretations5 currently firing — 2 · 1 · 2
What this company is and how it runs — written from structure, not news.
Nature view
Encompass Health runs 154 inpatient rehabilitation facilities across 36 states, taking patients discharged from acute care hospitals — stroke survivors, spinal cord injury patients, traumatic brain injury cases — and converting those admissions into intensive rehabilitation stays that qualify for Medicare's higher IRF payment rate. That higher payment rate only applies if at least 60% of each facility's annual admissions come from a specific list of qualifying conditions, so the entire revenue structure depends on keeping a steady stream of the right patients arriving within 72 hours of leaving an acute care hospital. To make that transfer window work reliably, the company has spent years embedding its patient assessment and handoff protocols directly inside partner hospitals' discharge planning systems, which means a new competitor cannot simply acquire an IRF licence and replicate the referral pipeline — the coordination agreements have to be built hospital by hospital over time. The single point of fragility runs in the opposite direction: because CMS sets the qualifying conditions and can revise the 60% threshold at any time, a rule change would hit all 154 facilities simultaneously rather than isolating the damage to one site.
How does this company make money?
Most revenue comes from Medicare, which pays the company a set amount for each rehabilitation stay based on how complex the patient's condition is — this score comes from a patient assessment instrument completed at admission. For patients receiving care at home after leaving a facility, Medicare pays in 60-day episodes. For hospice patients, Medicare pays a daily rate that varies by the level of care provided. The company also collects negotiated rates from commercial insurance plans for post-acute rehabilitation services.
What makes this company hard to replace?
An acute care hospital that wanted to stop using the company and open its own rehabilitation unit would face a Medicare IRF certification process, state licensing requirements, and a facility development timeline of 12 to 18 months before it could admit a single qualifying patient. Beyond the paperwork, the patient assessment and transfer protocols that make the 72-hour window work are already embedded in the hospital's own discharge planning systems, making the existing relationship the path of least resistance.
What limits this company?
Each of the 154 facilities must hit the 60% threshold on its own — Medicare measures compliance site by site, not across the network as a whole. If one facility's patient mix slips, that facility faces repayment demands or loss of its licence. There is no way to use strong performance at one location to cover a shortfall at another.
What does this company depend on?
The company cannot operate without Medicare IRF certification and the prospective payment rates CMS sets for it. It also needs state health department licences in all 36 states where it operates, licensed physical therapists and occupational therapists who meet each state's credentialing rules, Medicare home health and hospice certifications for its post-acute care services, and the referral relationships with acute care hospitals that put patients into IRF beds within 72 hours.
Who depends on this company?
Stroke patients and others with severe neurological injuries depend on the company for the intensive daily therapy that drives recovery — without IRF-level care, their rehabilitation would be slower and less intensive. Acute care hospitals depend on the company to take complex patients off their hands quickly; without those IRF beds available, hospitals risk Medicare readmission penalties for patients who stay too long or bounce back. Medicare Advantage plans that have specifically contracted for a post-acute care network stretching from inpatient rehabilitation through home-based services would lose that network if the company stopped operating.
How does this company scale?
Once the company has built the compliance systems, therapy protocols, and Medicare billing processes for one facility, those systems can be applied to additional facilities without being rebuilt from scratch. What does not scale easily is geography: patients must physically transfer within 72 hours of leaving an acute care hospital, so each new facility only serves the hospitals near it. Every new location also requires its own state licence and its own local pool of credentialed therapists.
What external forces can significantly affect this company?
The biggest external pressure is CMS itself — any change to IRF prospective payment rates or the 60% rule compliance threshold directly hits revenue across all 154 facilities at once. On the positive side, an aging population means more strokes and more complex surgeries, which naturally increases the number of patients who qualify for IRF care. State Medicaid funding levels also matter because patients who are covered by both Medicare and Medicaid affect the facility's revenue mix and how much uncompensated care it absorbs.
Where is this company structurally vulnerable?
If CMS changed the 60% rule — by removing conditions from the qualifying list, raising the required percentage, or tightening how audits are conducted — every one of the 154 facilities would be hit at the same time. Because all facilities run the same intake protocols, a single rule change would cause simultaneous admission-mix failures across the entire network rather than isolating the problem to a handful of sites.
Price is read as structure — trend, levels, range, peak and volatility drawn on the chart. It does not predict where price goes next.
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Multi-Year Up-Close-Week Share With Profitability And Book-Value Growth
Three observations describe the present configuration: a high share of the trailing three years' weekly closes were higher than the prior week, the company has reported positive net income in each of the last five annual periods, and the book-value-increase-consistency composite over the trailing 5 years is elevated.
Reads
Close In Upper Portion Of Recent Range, Bollinger Bands, And RSI
Current close sits in the upper portion of the 14-week high-low range; current close sits in the upper portion of its 20-week Bollinger Bands; RSI sits above its 20-week recent mean (Bollinger %B applied to RSI).
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.68%Below 5Y avg (1.09%)
Annual Rate
USD 0.76Paid quarterly
Payout Ratio
12.7%Sustainable
Consecutive Growth
1 yr
Paying Dividends
14 yr
Last Ex-Dividend
Jul 1, 2026
Last Payment
Jul 15, 2026
Screen for this company's dividend patterns
Find other companies where the same dividend readings fire.
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Three observations co-occur: a previously-cut dividend is growing back toward pre-cut levels, free cash flow has been positive each of the last three fiscal years, and revenue increased year-over-year in each of the last three fiscal years. The configuration describes recovery-in-progress alongside multi-year fundamental persistence.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
11.13BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Trailing P/E
19.30x
vs Medical Care Facilities peers
Updated Jul 18, 2026
Revenue (TTM)
6.07BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Profit Margin
10.04%
vs Medical Care Facilities peers
Updated Jul 18, 2026
Beta
0.6020x
vs all stocks
Updated Jul 18, 2026
52-Week Change
2.01%
vs all stocks
Updated Jul 18, 2026
Forward Annual Dividend Yield
0.68%
vs all stocks
Updated Jul 18, 2026
Market Capitalization
11.13BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Enterprise Value
14.42BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Trailing P/E
19.30x
vs Medical Care Facilities peers
Updated Jul 18, 2026
Gross Margin
95.95%
vs Medical Care Facilities peers
Updated Jul 18, 2026
Profit Margin
10.04%
vs Medical Care Facilities peers
Updated Jul 18, 2026
Operating Margin
19.01%
vs Medical Care Facilities peers
Updated Jul 18, 2026
Shares Outstanding
99.42MSharesUpdated Jul 18, 2026
Float Shares
97.92MSharesUpdated Jul 18, 2026
Shares Short
3.10MSharesUpdated Jul 18, 2026
Short Ratio
2.79days
vs all stocks
Updated Jul 18, 2026
Short % of Shares Outstanding
52-Week Low
92.77USDUpdated Jul 18, 2026
52-Week High
127.99USDUpdated Jul 18, 2026
52-Week Change
2.01%
vs all stocks
Updated Jul 18, 2026
Beta
0.6020x
vs all stocks
Updated Jul 18, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Rising Operating Income With Low Depreciation on a Capital-Heavy Balance Sheet
Three observations describe a low-D&A profile alongside rising operating income: operating income has increased year-over-year across the trailing four years, EBIT is close to EBITDA in the most recent period (small D&A), and non-current assets are a large share of total assets. The composition is consistent with under-depreciation or a young asset base whose depreciation has not yet caught up.
Reads
Multi-Year FCF With Growth And Margin
Four observations co-occur: free cash flow positive each of the last three fiscal years, revenue increased each of the last three fiscal years, trailing-statistics OCF margin elevated, and book value increased each of the last four fiscal years. The configuration describes multi-year fundamental persistence across cash flow, top line, margin, and equity accumulation.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is in the top 5% of Medical Care Facilities peersSignificant
Gross margin: 0.96Industry P95: 0.92
Financial Health
Altman Z-Score: safe zoneNotable
Altman Z-Score: 3.35
High earnings qualityNotable
Earnings Quality Score: 1.52
High structural barrier to entryNotable
Barrier to Entry: 1.24
Supply Chain
Downstream position: depends on 12 industries, supplies 5Notable
Outgoing: 5.00Incoming: 12.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Market cap is above the global medianNotable
Market cap (USD): 11,131,128,766Global Median: 1,131,585,792.619
Post-Cut Dividend Growth With FCF And RevenueMulti-Year Up-Close-Week Share With Profitability And Book-Value GrowthClose In Upper Portion Of Recent Range, Bollinger Bands, And RSIMulti-Year FCF With Growth And Margin
Rising Operating Income With Low Depreciation on a Capital-Heavy Balance SheetMulti-Year Up-Close-Week Share With Profitability And Book-Value GrowthClose In Upper Portion Of Recent Range, Bollinger Bands, And RSIMulti-Year FCF With Growth And Margin